About Blumberg Pharmaceuticals Private Limited
Data last updated:
Blumberg Pharmaceuticals Private Limited is a private limited company based in Gmc, Assam, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U24299AS2019PTC019374. Its GSTIN is 18AAICB5434E1ZS (Assam).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Biplob Roy and Santosh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Gmc, Assam.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.79 Cr, a decline of 28% compared to the previous year. For the same year it recorded a net profit of ₹20 Lakh (net margin 11.2%) and EBITDA of ₹28.24 Lakh (EBITDA margin 15.8%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years.
For more details, the company can be reached via its website blumbergpharmaceuticals.in.
Company details
Contact details
Blumberg Pharmaceuticals Private Limited's registered office is in Gmc, Assam. Its website is blumbergpharmaceuticals.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH/No. 9 Bhakti Vijay Bhawan Shishuram Choudhary Path, Bhairabtala Kalaphar, Gmc, Assam, India – 781018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Blumberg Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Blumberg Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Blumberg Pharmaceuticals Private Limited, buy the company report.
Financials of Blumberg Pharmaceuticals Private Limited
FY 2024 filings availableBlumberg Pharmaceuticals Private Limited reported revenue of ₹1.79 Cr (down 28% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 15% over three years, including a 28% fall in the latest year. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28.24 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.8% | ||||
| Net Profit Margin | 11.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Blumberg Pharmaceuticals Private Limited, buy the company report.
Board of directors of Blumberg Pharmaceuticals Private Limited
Blumberg Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Biplob Roy Also directs: Blumberg Healthcare Private Limited | Director | 20 Oct 2020 | 6 Years 0 Months | Current |
| Santosh Kumar Also directs: Mdecofount Healthcare Private Limited | Director | 20 Oct 2020 | 6 Years 0 Months | Current |
| Debabrata Singha Also directs: Blumberg Healthcare Private Limited | Director | 06 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Blumberg Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Achemic Pharmaceuticals (India) Private Limited | ₹1.79 Cr (FY 2025) | -7.0% | Patna, Bihar, India | |||
| Blumberg Pharmaceuticals Private Limitedthis company | ₹1.79 Cr (FY 2024) | ₹20 Lakh | 11.2% | -28.0% | Gmc, Assam, India | |
| Diocard Pharmaceuticals Private Limited | ₹1.79 Cr (FY 2025) | 23.0% | Vadodara, Gujarat, India | |||
| Puthujeevan Pharmaceuticals Private Limited | ₹1.79 Cr (FY 2024) | -16.0% | Kollam, Kerala, India |
To see the full peer comparison of Blumberg Pharmaceuticals Private Limited, buy the company report.
Auditor
Blumberg Pharmaceuticals Private Limited is audited by Subhashree and Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Subhashree and Associates | FY 2023 | 314406 |
Shareholding
The shareholding of Blumberg Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Blumberg Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Blumberg Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Blumberg Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Blumberg Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AAICB5434E1ZS | Assam | Active | 25 Nov 2019 |
To see the full GST registrations and return filing status of Blumberg Pharmaceuticals Private Limited, buy the company report.
Recent activity
Blumberg Pharmaceuticals Private Limited has 8 board changes on record since 2020: 3 appointments and 5 cessations. The latest: Gayatri Devi Pandit ceased to be Director on 19 Aug 2024.
Frequently asked questions
Blumberg Pharmaceuticals is an active private limited company based in Gmc, Assam, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 July 2019 (7+ years old) and is registered under CIN U24299AS2019PTC019374.
Blumberg Pharmaceuticals has 3 current directors:
- Biplob Roy - Director
- Santosh Kumar - Director
- Debabrata Singha - Director
The latest financial statements of Blumberg Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Blumberg Pharmaceuticals is 18AAICB5434E1ZS, registered in Assam.
The CIN (Corporate Identification Number) of Blumberg Pharmaceuticals is U24299AS2019PTC019374. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Blumberg Pharmaceuticals was incorporated on 17 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Blumberg Pharmaceuticals by revenue are Achemic Pharmaceuticals (India) Private Limited, Diocard Pharmaceuticals Private Limited, Puthujeevan Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Gayatri Devi Pandit ceased to be Director on 19 Aug 2024. Sanjay Kumar Pandit ceased to be Director on 19 Aug 2024. Debabrata Singha ceased to be Additional Director on 30 Nov 2021. Blumberg Pharmaceuticals has 8 board changes on record in total.
Blumberg Pharmaceuticals can be reached through the website blumbergpharmaceuticals.in. Its registered office is in Gmc, Assam, India.
The registered office of Blumberg Pharmaceuticals is at HNo. 9 Bhakti Vijay Bhawan Shishuram Choudhary Path, Bhairabtala Kalaphar, Gmc, Assam, India – 781018.
Blumberg Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
